Evommune, Inc. (EVMN) › Operating Cash FlowEvommune, Inc. (EVMN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: -$58.20M2025: -$76.44M-$76.44M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$76.44M-31.4%2024-$58.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share